Dalteparin sodium injection
Questions | Reviews
We don't currently have any questions about Dalteparin sodium injection.
Classification: Anticoagulant, low molecular weight heparin See Also: See also Heparins, Low Molecular Weight. Action/Kinetics: Peak plasma levels: 4 hr. t 1/2, SC: 3-5 hr. t 1/2 increased in those with chronic renal insufficiency requiring hemodialysis. Uses: To prevent deep vein thrombosis (DVT) in clients undergoing hip replacement or abdominal surgery who are at risk for thromboembolic complications (i.e., pulmonary embolism). High risk includes obesity, general anesthesia more than 30 min, malignancy, history of DVT or pulmonary embolism, age 40 and over. To prevent ischemic complications due to blood clot formation in life-threatening unstable angina and non-Q-wave MI in clients on concurrent aspirin therapy. Investigational: Systemic anticoagulation in venous and arterial thromboembolic complications. Special Concerns: See also Heparins, Low Molecular Weight. Also, the multiple dose vial contains benzyl alcohol that has been associated with a fatal "gasping syndrome" in premature infants. Side Effects: CV: Hemorrhage hematoma at injection site, wound hematoma, reoperation due to bleeding, postoperational transfusions. Hematologic: Thrombocytopenia. Hypersensitivity: Allergic reactions, including pruritus, rash, fever, injection site reaction, bulleous eruption, skin necrosis (rare), anaphylaxis. Miscellaneous: Pain at injection site. How Supplied: Injection: 2,500 IU/0.2 mL, 5,000 IU/0.2 mL, 10,000 IU/mL
Dosage
|